跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-FINASTERIDE
Authorized
STANDARD
MINT-FINASTERIDE
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ccbecd0b4a7112aa
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
ccbecd0b4a7112aa
Drug Approval Canada Name
MINT-FINASTERIDE
Product Name
MINT-FINASTERIDE
Status
Marketed
Status Date
2024-05-15
Original Market Date
2024-05-15
Din
02537427
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
84:16.00
Atc Original
D11AX10 FINASTERIDE
Atc Name
d 11 ax 10
Aig Number
0124110002
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
FINASTERIDE
1 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ccbecd0b4a7112aa
Type
Standard
Back to Health Canada Approvals
MINT-FINASTERIDE - Health Canada Drug Approval Details